3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
86
Breast Neoplasms
70
Prostatic Neoplasms
34
Head and Neck Neoplasms
26
Lung Neoplasms
24
Colorectal Neoplasms
24
Ovarian Neoplasms
22
Uterine Cervical Neoplasms
21
Endometrial Neoplasms
16
Brain Neoplasms
15
Rectal Neoplasms
12
Pancreatic Neoplasms
11
Colonic Neoplasms
11
Urinary Bladder Neoplasms
9
Melanoma
9
Lymphoma
9
Leukemia
9
Depression
9
Stomach Neoplasms
8
Pain
8
Motor Activity
8
Colorectal Neoplasms, Hereditary Nonpolyposis
8
Sarcoma
7
Oropharyngeal Neoplasms
7
Multiple Myeloma
7
Hematologic Neoplasms
7
COVID-19
7
Vulvar Neoplasms
6
Health Behavior
6
Glioma
6
Interventions
Mental Status and Dementia Tests
3
Psychiatric Rehabilitation
2
Magnetic Resonance Spectroscopy
2
Trastuzumab
1
Surveys and Questionnaires
1
Paclitaxel
1
Folfox protocol
1
Fluorodeoxyglucose F18
1
Doxorubicin
1
Docetaxel
1
Diffusion Tensor Imaging
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Aromatase Inhibitors
1
2,2'-dithiodiethanesulfonic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neurotoxicity Syndromes
×
Surveys and Questionnaires
×
Clear all
NCT02890030
2020-04-08
The Platinum Study Comparison Group
Indiana University
Completed
102 enrolled